GLP-1 Medications Available in Canada Below are the GLP-1 medications currently available in Canada, grouped by category
The biological functions of stromal cell-derived factors 1 and 1 (SDF-1 and SDF- 1, CXCL12), macrophage-derived chemokine (MDC, CCL22), interferon-inducible T cell -chemoattractant (ITAC, CXCL11), inflammatory protein-10 (IP10, CXCL10), monokine-induced by gamma interferon (MIG, CXCL9), eotaxin (CCL11), granulocyte chemotactic protein 2 (GCP2, CXCL6), and Gro (CXCL2) have been shown to be substrates for proteolytic modification by DPP4
The Incretin System in Healthy Humans: The Role of GIP and GLP-1
Intrathecal injection of exendin-4 reduced pain sensitivity as assessed by the von Frey test and decreased neuroinflammation, with reduced TNF, IL-1 and IL-6 levels, thus demonstrating that analgesic effects of GLP-1R signalling were directly correlated with its anti-neuroinflammation activity [89]
Tammy brings over 25 years of experience representing plaintiffs in all areas of mass tort and personal injury law
The accumulated data, along with precedent experiments for preclinical and clinical action, further enforce the clinical and mechanistic reasoning to consider CT-868 as an additional therapeutic to insulin in treating T1D
